MY ACCOUNT | NEWSLETTER |

Pain management in domestic rabbits undergoing elective orchiectomy or ovariohysterectomy”


Pain control is a challenge in domestic rabbits (Oryctolagus cuniculus). The objective of this study was to describe the effect of maropitant on pain scores, food intake, and fecal output in domestic rabbits following elective orchiectomy or ovariohysterectomy. 

Rabbits that underwent orchiectomy or ovariohysterectomy at three institutions were randomly assigned to one of three treatment groups: low-dose maropitant (2 mg/kg SC once), high-dose maropitant (10 mg/kg SC once), and control (1 mL/kg saline SC once). Rabbits were monitored using video surveillance postoperatively. Pain scores were assessed by three blinded observers, and results were grouped into time frames after surgery. Food intake and fecal output were measured until discharge. 

There were no local side effects with maropitant administration. There were no statistically significant differences between groups with regard to pain behaviors. An inverse trend was noted between increasing maropitant dosage versus food intake and fecal output, which was not statistically significant. 

To conclude, maropitant at 2 mg/kg SC and at 10 mg/kg SC failed to significantly reduce pain when compared to control group. 



“Use of maropitant for pain management in domestic rabbits (Oryctolagus cuniculus) undergoing elective orchiectomy or ovariohysterectomy”. Megan Roeder, et al. Journal of Exotic Pet Medicine. Volume 47, October 2023, Pages 14-20. 

Source: https://www.sciencedirect.com/science/article/pii/S1557506323000617 

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Manoeuvring the innovative drug delivery systems for veterinary therapeutics: Present day demand

Like0
Dislike0

Stereotactic Radiation Therapy Planning, Dose Prescription and Delivery in Veterinary Medicine: A Systematic Review on Completeness of Reporting and Proposed Reporting Items

Like0
Dislike0

Management and medicine of backyard poultry

Like0
Dislike0

Horse makes immediate recovery following removal of large nasal mass

Like0
Dislike0

Zoetis Receives Conditional Approval for Dectomax®-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top